BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34549887)

  • 1. Alteration of PPAR-GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells.
    Esmaeili S; Salari S; Kaveh V; Ghaffari SH; Bashash D
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1818. PubMed ID: 34549887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ activation by pioglitazone enhances the anti-proliferative effects of doxorubicin on pro-monocytic THP-1 leukemia cells via inducing apoptosis and G2/M cell cycle arrest.
    Ghasemi H; Jamshidi A; Ghatee MA; Mazhab-Jafari K; Khorasani M; Rahmati M; Mohammadi S
    J Recept Signal Transduct Res; 2022 Oct; 42(5):429-438. PubMed ID: 34645362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells.
    Esmaeili S; Yousefi AM; Delshad M; Bashash D
    Mol Genet Genomic Med; 2023 Mar; 11(3):e2106. PubMed ID: 36398521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analgesic effects of pioglitazone in the bone cancer pain rats via regulating the PPARγ/PTEN/mTOR signaling pathway in the spinal dorsal horn.
    Gu W; Sun Y; Gu W; Huang Y; Bo J; Zhou L; Ma Z; Gu X; Zhang W
    Biomed Pharmacother; 2020 Nov; 131():110692. PubMed ID: 32942156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
    Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Int J Biochem Cell Biol; 2020 May; 122():105739. PubMed ID: 32169580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PI3K Signaling Intensified the Antileukemic Effects of Pioglitazone: New Insight into the Application of PPARγ Stimulators in Acute Lymphoblastic Leukemia.
    Mokhtari Y; Yousefi AM; Bashash D
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):546-556. PubMed ID: 37786817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
    To KKW; Wu WKK; Loong HHF
    Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN.
    Lee KS; Park SJ; Hwang PH; Yi HK; Song CH; Chai OH; Kim JS; Lee MK; Lee YC
    FASEB J; 2005 Jun; 19(8):1033-5. PubMed ID: 15788448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
    Zhou W; Xu S; Chen X; Wang C
    Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia.
    Tsao T; Kornblau S; Safe S; Watt JC; Ruvolo V; Chen W; Qiu Y; Coombes KR; Ju Z; Abdelrahim M; Schober W; Ling X; Kardassis D; Meyer C; Schimmer A; Kantarjian H; Andreeff M; Konopleva M
    Cancer Res; 2010 Jun; 70(12):4949-60. PubMed ID: 20501850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b/PTEN.
    Wang N; Yang B; Jin J; He Y; Wu X; Yang Y; Zhou W; He Z
    J Gene Med; 2022 Mar; 24(3):e3404. PubMed ID: 34913223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
    Wang Y; Zhou Q; Ma JJ
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
    Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.
    Tsubaki M; Takeda T; Tomonari Y; Kawashima K; Itoh T; Imano M; Satou T; Nishida S
    J Cell Physiol; 2018 Apr; 233(4):3638-3647. PubMed ID: 29030979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.
    Patel L; Pass I; Coxon P; Downes CP; Smith SA; Macphee CH
    Curr Biol; 2001 May; 11(10):764-8. PubMed ID: 11378386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
    Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
    Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.